Mirata Pharmaceuticals
Plymouth Meeting, US · Founded 2016 · 1 known investors
Mirata Pharmaceuticals is developing pain-relieving drugs intended to provide the analgesic benefits of opioids without their addictive properties and serious side effects. It targets patients and physicians seeking safer alternatives to prescription opioids.
BiotechHealthtech
Founders & leadership
JJ
John JohnsonDirector
BH
Brian HubbardDirector
JY
Jason Y ZhangDirector
MG
Maurits GeerlingsDirector
MC
Matthew CallahanExecutive Officer, Director
JF
Joseph F LovettDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$7.1MraisedJan 2019 · 11 investors · PharmaceuticalsRule 506(b)
▶$7.1MraisedJan 2019 · 11 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- John JohnsonDirector
- Joseph F LovettDirector
- Brian HubbardDirector
- Jason Y ZhangDirector
- Maurits GeerlingsDirector
- Matthew CallahanExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $7.1M
- Proceeds to insiders
- $12.7K
- First sale
- Jun 2018
- Incorporated
- Limited Liability Company, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.